Publications

Endocan as a Marker of Endotheliitis in Covid-19 Patients: Modulation by Veno-Venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-Angiotensin-Aldosterone System Inhibitors

AuthID
P-017-YSZ

Author(s)

Reina-Couto, M

Alves, D

Silva-Pereira, C

Pereira-Terra, P

Martins, S

Bessa, J

Teixeira-Santos, L

Pinho, D

Morato, M

Dias, CC

Sarmento, A

Tavares, M

Guimaraes, JT

Roncon-Albuquerque, R

Paiva, JA

Albino-Teixeira, A

Sousa, T

Document Type

Article

Year published

2025

Published

in INFLAMMATION RESEARCH, ISSN: 1023-3830

Volume: 74, Issue: 1

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1007/s00011-024-01964-8

Pubmed: 39862311

Scopus: 2-s2.0-85217001794

Wos: WOS:001406434100003

Source Identifiers

ISSN: 1023-3830

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Endocan as a Marker of Endotheliitis in Covid-19 Patients: Modulation by Veno-Venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-Angiotensin-Aldosterone System Inhibitors

Useful Links

Get Help

Federated Authentication (Click on the image)

Endocan as a Marker of Endotheliitis in Covid-19 Patients: Modulation by Veno-Venous Extracorporeal Membrane Oxygenation, Arterial Hypertension and Previous Treatment with Renin-Angiotensin-Aldosterone System Inhibitors

Useful Links

Get Help